JACC: Case Reports (Jun 2024)

Heart Failure With Reduced Ejection Fraction in a Patient With Erdheim-Chester Disease on Dabrafenib

  • Santiago Saenz-Ancira, MD,
  • Javier Higuera-Ornelas, MD,
  • Breno Bernades-Souza, MD,
  • Ryan Severdija, MD,
  • Maria Jose Santa Ana-Bayona, MS,
  • Maria Silvana Salazar, MD,
  • Moises A. Vazquez, MD,
  • Jose Antonio Luna-Alvarez, MD

Journal volume & issue
Vol. 29, no. 12
p. 102374

Abstract

Read online

A 54-year-old woman with a diagnosis of Erdheim-Chester disease under therapy with dabrafenib presents with clinical signs of heart failure. After discontinuing the offending medication and initiating guideline-directed medical therapy for heart failure with reduced ejection fraction, the clinical picture improved.

Keywords